Company Overview - Glucotrack, Inc. is a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes [5] - The company is currently developing a long-term implantable continuous blood glucose monitoring (CBGM) system [5][6] Key Appointment - Dr. Guillermo Umpierrez has been appointed as a new member of Glucotrack's Medical Advisory Board, effective immediately [1] - Dr. Umpierrez is a Professor of Medicine at Emory University and has extensive experience in diabetes care and clinical research [2] Technology Development - Glucotrack's CBGM system is designed to directly measure blood glucose levels without the lag time associated with traditional continuous glucose monitoring systems [3] - The CBGM system features a sensor life of 3 years, no wearable component, and aims to improve real-time accuracy, longevity, comfort, and supply management [3][6] Clinical Development - Dr. Umpierrez's expertise will be instrumental as Glucotrack advances its CBGM technology through clinical development and into human clinical trials [2] - The company aims to make glucose monitoring less burdensome for individuals living with diabetes [2]
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member